ScholarIQanswers from OpenAlex & ORCID
Stan B. Kaye
ResearcherPublications, citations & collaboration network
Stan B. Kaye is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Stan B. Kaye have?
ScholarIQindexed works
Stan B. Kaye has 431 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Stan B. Kaye have?
ScholarIQcitation count
Stan B. Kaye has 29,803 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Stan B. Kaye?
ScholarIQh-index
Stan B. Kaye has an h-index of 78 in OpenAlex.
What is the i10-index of Stan B. Kaye?
ScholarIQi10-index
Stan B. Kaye has an i10-index of 184 in OpenAlex.
What is the ORCID of Stan B. Kaye?
ScholarIQorcid
The ORCID for Stan B. Kaye is on the source record.
What is the OpenAlex record for Stan B. Kaye?
ScholarIQopenalex
The OpenAlex for Stan B. Kaye is on the source record.
What are the most-cited papers on Stan B. Kaye?
ScholarIQmost cited works
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers
Peter C.C. Fong, David S. Boss, Timothy A. Yap, Andrew Tutt, Peijun Wu, Marja Mergui‐Roelvink, Peter G. Mortimer, Helen Swaisland, Alan Lau, Mark J. O’Connor, Alan Ashworth, James Carmichael, Stan B. Kaye, Jan H.M. Schellens, Johann S. de Bono
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan, Jermaine Coward, Robert C. Bast, Andy Berchuck, Jonathan S. Berek, James D. Brenton, George Coukos, Christopher Crum, Ronny Drapkin, Dariush Etemadmoghadam, Michael Friedländer, Hani Gabra, Stan B. Kaye, Christopher J. Lord, Ernst Lengyel, Douglas A. Levine, Iain A. McNeish, Usha Menon, Gordon B. Mills, Kenneth P. Nephew, Amit M. Oza, Anil K. Sood, Euan A. Stronach, Henning Walczak, David D.L. Bowtell, Frances R. Balkwill
Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven
Gerhardt Attard, Alison Reid, Timothy A. Yap, Florence I. Raynaud, Mitch Dowsett, S. Settatree, Mary Barrett, Christopher Parker, Vanessa Martins, Elizabeth Folkerd, Jeremy Clark, Colin S. Cooper, Stan B. Kaye, David P. Dearnaley, Gloria Lee, Johann S. de Bono
First-in-Human Phase I Study of Pictilisib (GDC-0941), a Potent Pan–Class I Phosphatidylinositol-3-Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors
Debashis Sarker, Joo Ern Ang, Richard D. Baird, Rebecca Kristeleit, Krunal Shah, Víctor Moreno, Paul A. Clarke, Florence I. Raynaud, Gallia G. Levy, Joseph A. Ware, Kathryn Mazina, Ray Lin, Jenny Wu, Jill Fredrickson, Jill M. Spoerke, Mark R. Lackner, Yibing Yan, Lori S. Friedman, Stan B. Kaye, Mika K. Derynck, Paul Workman, Johann S. de Bono